You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 23, 2025

Details for Patent: 10,500,172


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,500,172 protect, and when does it expire?

Patent 10,500,172 protects OSMOLEX ER and is included in one NDA.

Summary for Patent: 10,500,172
Title:Composition and method for treating neurological disease
Abstract: The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.
Inventor(s): Meyer; Glenn A. (Wilmington, NC), Faour; Joaquina (Ciudad Autonoma de Buenos Aires, AR), Pastini; Ana Cristina (Ciudad Autonoma de Buenos Aires, AR), Befumo; Marcelo Fernando (Ciudad Autonoma de Buenos Aires, AR)
Assignee: Osmotica Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag (Budapest, HU)
Application Number:16/250,686
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,500,172: A Comprehensive Guide

Introduction

When delving into the specifics of a patent, such as United States Patent 10,500,172, it is crucial to understand the broader context of patent law, search tools, and the intricacies of patent claims. This article will provide a detailed analysis of the scope and claims of this patent, along with an overview of the relevant tools and guidelines that shape the patent landscape.

Understanding Patent Searches

To begin with, conducting a thorough patent search is essential for understanding the prior art and the novelty of a patent. The USPTO offers several tools for this purpose, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool provides enhanced access to prior art with modern interfaces and flexible search capabilities[1].

Patent Public Search Tool

The Patent Public Search tool is a powerful resource for searching patents. It allows users to select from two modern interfaces, providing improved access to prior art. This tool is particularly useful for identifying related patents and understanding the patent family of a specific application[1].

Global Dossier

The Global Dossier service is another valuable resource, offering access to the file histories of related applications from participating IP Offices. This service helps in identifying office actions, saving documents for later review, and downloading application documents, all through a single portal[1].

Drafting Patent Claims

Patent claims are the heart of any patent application. According to U.S. patent law, claims must "particularly point out" and "distinctly" claim the subject matter of the invention. This requirement is critical, as claims that are indefinite can be found invalid[2].

Subjective Claims Terms

When drafting patents, especially those involving subjective terms, it is important to provide numerous and meaningful examples. The courts have recognized the inherent limitations of language, requiring a balance between precision and clarity. For instance, in cases like Interval Licensing LLC v. AOL, Inc., the court held that a term like "unobtrusive manner" was too subjective and lacked objective indication of how content images should be displayed[2].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset is invaluable for analyzing claim-level statistics and understanding the scope of patents[3].

Subject Matter Eligibility

For any patent, subject matter eligibility is a critical issue. The USPTO's 2024 Guidance Update emphasizes the importance of the practical applicability analysis under Step 2A, Prong Two, for overcoming section 101 rejections. This involves demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem[4].

Two-Pronged Framework

The two-pronged framework introduced by the USPTO separates the analysis into two steps. Prong One determines if the claim recites an abstract idea, and if so, Prong Two evaluates whether the claim elements integrate the abstract idea into a practical application. This framework is crucial for AI inventions, which often face section 101 rejections[4].

Analyzing United States Patent 10,500,172

Patent Overview

United States Patent 10,500,172, while not specifically detailed here, would typically involve a thorough review of its claims, specifications, and any prior art cited.

Claims Analysis

  • Claim Structure: The claims of the patent should be analyzed to determine if they meet the requirements of being particularly pointed out and distinctly claimed.
  • Subject Matter Eligibility: Using the two-pronged framework, it would be necessary to evaluate if the claims are directed to a specific technological advancement and if they integrate any abstract ideas into a practical application.
  • Examples and Specifications: The specification should provide clear examples and explanations to support any subjective terms used in the claims.

Prior Art and Patent Family

  • Global Dossier: Utilizing the Global Dossier service to identify related applications and prior art cited by other IP Offices.
  • Patent Public Search: Conducting a thorough search using the Patent Public Search tool to ensure the novelty of the invention.

Practical Applicability

  • Step 2A, Prong Two: Demonstrating how the claims reflect an improvement in the functioning of a computer or another technical field. This could involve showing technical explanations in the specification and evaluating whether the claim accurately reflects these improvements[4].

Key Considerations for Patent Examiners

When facing section 101 rejections, understanding how the assigned patent examiner applies the subject matter eligibility analysis is crucial. Different examiners may have varying interpretations of the framework, so it is important to tailor the argument to the specific examiner's approach[4].

Small Claims Patent Court

While not directly related to the analysis of a specific patent, the concept of a small claims patent court is an ongoing discussion. This potential court would aim to provide a more accessible and cost-effective way for resolving patent disputes, which could impact the overall patent landscape[5].

Conclusion

Analyzing the scope and claims of a patent like United States Patent 10,500,172 involves a multifaceted approach. It requires a deep understanding of patent search tools, the intricacies of drafting patent claims, and the subject matter eligibility framework. Here are the key takeaways:

  • Thorough Patent Searches: Utilize tools like the Patent Public Search and Global Dossier to ensure the novelty of the invention.
  • Clear and Distinct Claims: Ensure claims are particularly pointed out and distinctly claimed, with clear examples and specifications.
  • Subject Matter Eligibility: Demonstrate practical applicability under Step 2A, Prong Two, to overcome section 101 rejections.
  • Understanding Examiner Approaches: Tailor arguments to the specific examiner's interpretation of the subject matter eligibility framework.

Key Takeaways

  • Conduct thorough patent searches using advanced tools.
  • Draft clear and distinct claims with meaningful examples.
  • Demonstrate practical applicability to overcome subject matter eligibility rejections.
  • Understand and adapt to the examiner's approach.

FAQs

Q: What is the importance of the Patent Public Search tool in patent analysis?

A: The Patent Public Search tool is crucial for accessing prior art and ensuring the novelty of an invention. It provides enhanced and flexible search capabilities, replacing legacy tools.

Q: How do subjective terms affect patent claims?

A: Subjective terms can make claims indefinite if not supported by clear examples and specifications. It is essential to provide numerous and meaningful examples to meet the requirements of U.S. patent law.

Q: What is the role of the two-pronged framework in subject matter eligibility?

A: The two-pronged framework helps determine if a claim is directed to an abstract idea and if it integrates that idea into a practical application. This is particularly important for AI inventions facing section 101 rejections.

Q: Why is understanding the patent examiner's approach important?

A: Different patent examiners may apply the subject matter eligibility framework differently. Understanding their approach can help in developing a successful strategy to overcome rejections.

Q: What is the potential impact of a small claims patent court?

A: A small claims patent court could provide a more accessible and cost-effective way for resolving patent disputes, potentially impacting the overall patent landscape by making it easier for smaller entities to enforce their patents.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. BIPC - Practical Advice for Drafting Patents with Subjective Claims Terms: https://www.bipc.com/practical-advice-for-drafting-patents-with-subjective-claims-terms
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Baker Botts - The Importance of Prong Two of Step 2A for AI Inventions: https://www.bakerbotts.com/thought-leadership/publications/2024/september/the-importance-of-prong-two-of-step-2a-for-ai-inventions
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,500,172

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 DISCN Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-004 Apr 22, 2020 DISCN Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 DISCN Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-003 Feb 16, 2018 DISCN Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF DRUG-INDUCED EXTRAPYRAMIDAL REACTION IN ADULT PATIENTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.